Urolog. pro Praxi, 2009; 10(2): 72-78

Metabolic problems in therapy of urolithiasis

doc. MUDr. David Stejskal, Ph.D., MBA, EurChem
Oddělení laboratorní medicíny Nemocnice Šternberk

The clear issue of the publication is given recurrent urolithiasis in terms of the division and then its primary prevention and selective

and non-selective secondary prevention.

Keywords: Recurrence form of urolithiasis, secondary prevention, diet, drinking regime.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal D, EurChem. Metabolic problems in therapy of urolithiasis. Urol. praxi. 2009;10(2):72-78.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pak CY. Kidney stones. Lancet, 1998; 351: 1797-1801. Go to original source... Go to PubMed...
    2. Pak CY. Nephrolithiasis. Endocrinol Metab Clin North Am, 2002; 31: 895-914. Go to original source... Go to PubMed...
    3. Coe FL, Parks JH. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002; 90: 361-364. Go to original source... Go to PubMed...
    4. Ashby RA, Sleet RJ. The role of citrate complexes in preventing urolithiasis. Clin Chim Acta, 1992; 210: 157-165. Go to original source... Go to PubMed...
    5. Schwille PO, Scholz D, Engelhardt W. Is increased intestinal calcium absorption in human calcium urolithiasis a feature of a hormonal imbalance? Hepatogastroenterology, 1981; 28: 131-134. Go to PubMed...
    6. Schwille PO, Schmiedl A, Manoharan M. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Clin Chem Lab Med, 2004; 42: 283-293. Go to original source... Go to PubMed...
    7. Resnick MI, Pak CY. Urolithiasis. A medical and surgical reference. W. B. Saunders Company, 1990: 197 s.
    8. Pearle SM, Calhoun EA, Curhan GC. Urolithiasis. In: Urologic diseases in America. NIH, 2004: 3-43 s. Go to PubMed...
    9. Stejskal D, Jabor A. Urolitiáza. In: Encyklopedie laboratorní medicíny IV. SEKK s.r.o., elektronická publikace, 2005.
    10. Stejskal D, Stejskal P, Bartek J, Mohapl P. Metabolická onemocnění hromadného výskytu. Biovendor, 1996: 191 s.
    11. Stejskal D. Urolitiáza. Grada Publishing, 2007: 182 s.
    12. Rhodes DC, Hinsman EJ, Rhodes JA, Hawkins EC. Urinary Tamm-Horsfall glycoprotein concentrations in normal and urolithiasis-affected male cats determined by an ELISA. Zentralbl Veterinarmed A, 1992; 39: 621-634. Go to original source... Go to PubMed...
    13. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BE. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med, 1976; 294: 249-252. Go to original source... Go to PubMed...
    14. Hennequin C, Lalanne V, Daudon M, Lacour B, Drueke T. A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res, 1993; 21: 101-108. Go to original source... Go to PubMed...
    15. Tiselius HG. Epidemiology and medical management of stone disease. BJU Int, 2003; 91: 758-767. Go to original source... Go to PubMed...
    16. Moe OW. Kidney stones: pathophysiology and medical management. The Lancet, 2006; 367: 333-344. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.